H R Brunner
Overview
Explore the profile of H R Brunner including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
566
Citations
4262
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
21.
Cugno M, Agostoni P, Brunner H, Gardinali M, AGOSTONI A, Nussberger J
Clin Sci (Lond)
. 2000 Oct;
99(5):461-6.
PMID: 11052927
Induction of congestive heart failure by high-frequency pacing has been reported to increase plasma levels of immunoreactive kinins in dogs. In the present study, we evaluated plasma bradykinin levels in...
22.
Maillard M, Rossat J, Brunner H, Burnier M
J Pharmacol Exp Ther
. 2000 Oct;
295(2):649-54.
PMID: 11046101
Tasosartan is a long-acting angiotensin II (AngII) receptor blocker. Its long duration of action has been attributed to its active metabolite enoltasosartan. In this study we evaluated the relative contribution...
23.
Chiolero A, Maillard M, Nussberger J, Brunner H, Burnier M
Hypertension
. 2000 Oct;
36(4):631-7.
PMID: 11040249
The purpose of this study was to evaluate the contribution of renal sodium handling by the proximal tubule as an independent determinant of blood pressure responsiveness to salt in hypertension....
24.
Gerc V, Favrat B, Brunner H, Burnier M
Blood Press Monit
. 2000 Oct;
5(4):203-9.
PMID: 11035861
Background: Because ambulatory blood pressure monitoring (ABPM) is not available everywhere, the objective of the study was to determine whether nurse-measured blood pressure could be an acceptable substitute to ABPM....
25.
Hayoz D, Bizzini G, Noel B, Depairon M, Burnier M, Fauveau C, et al.
Rheumatology (Oxford)
. 2000 Oct;
39(10):1132-8.
PMID: 11035135
Objective: To assess whether vasopressin V1a receptor blockade reduces the abnormal vasoactive response to cold in patients suffering from Raynaud's phenomenon (RP). Methods: SR 49059, an orally active, non-peptidic vasopressin...
26.
Murat A, Pellieux C, Brunner H, Pedrazzini T
J Biol Chem
. 2000 Oct;
275(52):40867-73.
PMID: 11016940
Chronic stimulation of the renin-angiotensin system induces an elevation of blood pressure and the development of cardiac hypertrophy via the actions of its effector, angiotensin II. In cardiomyocytes, mitogen-activated protein...
27.
Pellieux C, Sauthier T, Aubert J, Brunner H, Pedrazzini T
J Hypertens
. 2000 Sep;
18(9):1307-17.
PMID: 10994762
Objective: In addition to its haemodynamic effects, angiotensin II (AngII) is thought to contribute to the development of cardiac hypertrophy via its growth factor properties. The activation of mitogen-activated protein...
28.
Waeber B, Burnier M, Brunner H
J Cardiovasc Pharmacol
. 2000 Jun;
35 Suppl 3:S23-6.
PMID: 10854048
Low adherence of hypertensive patients to prescribed antihypertensive medications is a major cause of unsatisfactory blood pressure control. Several factors might have a negative influence on long-term adherence with treatment,...
29.
Pechere-Bertschi A, Maillard M, Stalder H, Brunner H, Burnier M
Clin Sci (Lond)
. 2000 May;
98(6):697-702.
PMID: 10814607
The purpose of the present study was to evaluate prospectively blood pressure and the renal haemodynamic response to salt during the normal menstrual cycle. A total of 35 healthy normotensive...
30.
Morgan T, Brunner H, Aubert J, Wang Q, Griffiths C, Delbridge L
J Hypertens
. 2000 Apr;
18(4):445-51.
PMID: 10779096
Objective: The objective of this study was to determine whether cardiac hypertrophy in hypertensive rats could be reduced and normalized by intermittent reduction of blood pressure, and to determine whether...